Back to 
STATE STREET CORP
STATE STREET CORP
LYEL5 quarters
Position history for STATE STREET CORP's holdings in LYELL IMMUNOPHARMA INC
Yes. State Street holds 185,322 shares of LYEL (Lyell Immunopharma), worth $2.6M, as of its Q2 2026 13F filing. It increased the position by 112,800 shares (+155.5%) from Q1 2026. State Street has held LYEL in every 13F on record since Q2 2025, 5 quarterly filings.
Current Value
$2.6M
Current Shares
185,322
Total Value Change
+$2.3M
Total Shares Change
+151,475
Quarter-by-Quarter History
Other major holders of LYEL: VANGUARD GROUP INC, VANGUARD CAPITAL MANAGEMENT LLC, BlackRock, Inc.